Welcome to LookChem.com Sign In|Join Free

CAS

  • or

27298-97-1

Post Buying Request

27298-97-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

27298-97-1 Usage

Chemical Properties

clear colorless to light yellow liquid

Uses

Different sources of media describe the Uses of 27298-97-1 differently. You can refer to the following data:
1. (S)-(-)-1-(4-Bromophenyl)ethylamine is utilized as an important raw material in organic synthesis. It also serves as an intermediate in organic synthesis and pharmaceuticals and agrochemicals.
2. (S)-(-)-1-(4-Bromophenyl)ethylamine may be used in the synthesis of (S)-1-(1-(4-bromophenyl) ethyl)-2-cyano-3-(quinoline-5-yl) guanidine, which is an intermediate to prepare a potent and selective antagonist and radioligand for rat P2X7 receptors.

Check Digit Verification of cas no

The CAS Registry Mumber 27298-97-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,7,2,9 and 8 respectively; the second part has 2 digits, 9 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 27298-97:
(7*2)+(6*7)+(5*2)+(4*9)+(3*8)+(2*9)+(1*7)=151
151 % 10 = 1
So 27298-97-1 is a valid CAS Registry Number.
InChI:InChI=1/C8H10BrN/c1-6(10)7-2-4-8(9)5-3-7/h2-6H,10H2,1H3/p+1/t6-/m0/s1

27298-97-1 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (B3674)  (S)-(-)-1-(4-Bromophenyl)ethylamine  >98.0%(GC)(T)

  • 27298-97-1

  • 5g

  • 1,350.00CNY

  • Detail
  • TCI America

  • (B3674)  (S)-(-)-1-(4-Bromophenyl)ethylamine  >98.0%(GC)(T)

  • 27298-97-1

  • 25g

  • 4,990.00CNY

  • Detail
  • Alfa Aesar

  • (L20080)  (S)-(-)-1-(4-Bromophenyl)ethylamine, ChiPros, 99%, ee 98%   

  • 27298-97-1

  • 1g

  • 821.0CNY

  • Detail
  • Alfa Aesar

  • (L20080)  (S)-(-)-1-(4-Bromophenyl)ethylamine, ChiPros, 99%, ee 98%   

  • 27298-97-1

  • 5g

  • 2727.0CNY

  • Detail
  • Alfa Aesar

  • (L20080)  (S)-(-)-1-(4-Bromophenyl)ethylamine, ChiPros, 99%, ee 98%   

  • 27298-97-1

  • 25g

  • 10876.0CNY

  • Detail
  • Aldrich

  • (18072)  (S)-(−)-1-(4-Bromophenyl)ethylamine  ≥98.0% (sum of enantiomers, GC)

  • 27298-97-1

  • 18072-1G

  • 2,707.38CNY

  • Detail
  • Aldrich

  • (18072)  (S)-(−)-1-(4-Bromophenyl)ethylamine  ≥98.0% (sum of enantiomers, GC)

  • 27298-97-1

  • 18072-5G

  • CNY

  • Detail

27298-97-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name (S)-(-)-4-Bromo-α-phenylethylamine

1.2 Other means of identification

Product number -
Other names S-(-)-4-Bromo-alpha-phenylethylamine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:27298-97-1 SDS

27298-97-1Relevant articles and documents

Synthesis method of garafloxacin intermediate

-

Paragraph 0025; 0040-0043; 0050-0053, (2021/09/26)

The invention discloses a synthesis method of a garafloxacin intermediate (1R)-5-bromo-2, 3-dihydro-1-methyl-1H-isoindole; the synthesis method comprises the following steps of: taking a garafloxacin intermediate as a raw material; the method comprises the following steps: step 1, by taking R(+)-alpha-phenylethylamine as a raw material and lewis acid as a catalyst, carrying out bromine bromination reaction to obtain a compound 2; 2, placing the compound 2 in a solvent, adding hydrochloric acid, paraformaldehyde and a catalyst, and carrying out chloromethylation reaction to obtain a compound 3; 3, dissolving the compound 3 in a solvent, adding alkali, and heating the mixture for reaction to obtain a compound 1. The method is simple in reaction, short in route, less in three wastes, environment-friendly, high in yield of each step, less in waste of raw materials and reagents, and especially suitable for industrial production.

Mapping the substrate scope of monoamine oxidase (MAO-N) as a synthetic tool for the enantioselective synthesis of chiral amines

Herter, Susanne,Medina, Florian,Wagschal, Simon,Benha?m, Cyril,Leipold, Friedemann,Turner, Nicholas J.

, p. 1338 - 1346 (2017/10/06)

A library of 132 racemic chiral amines (α-substituted methylbenzylamines, benzhydrylamines, 1,2,3,4-tetrahydronaphthylamines (THNs), indanylamines, allylic and homoallylic amines, propargyl amines) was screened against the most versatile monoamine oxidase (MAO-N) variants D5, D9 and D11. MAO-N D9 exhibited the highest activity for most substrates and was applied to the deracemisation of a comprehensive set of selected primary amines. In all cases, excellent enantioselectivity was achieved (e.e. >99%) with moderate to good yields (55–80%). Conditions for the deracemisation of primary amines using a MAO-N/borane system were further optimised using THN as a template addressing substrate load, nature of the enzyme preparation, buffer systems, borane sources, and organic co-solvents.

Enantioselective synthesis of amines via reductive amination with a dehydrogenase mutant from Exigobacterium sibiricum: Substrate scope, co-solvent tolerance and biocatalyst immobilization

L?we, Jana,Ingram, Aaron A.,Gr?ger, Harald

, p. 1387 - 1392 (2018/03/21)

In recent years, the reductive amination of ketones in the presence of amine dehydrogenases emerged as an attractive synthetic strategy for the enantioselective preparation of amines starting from ketones, an ammonia source, a reducing reagent and a cofactor, which is recycled in situ by means of a second enzyme. Current challenges in this field consists of providing a broad synthetic platform as well as process development including enzyme immobilization. In this contribution these issues are addressed. Utilizing the amine dehydrogenase EsLeuDH-DM as a mutant of the leucine dehydrogenase from Exigobacterium sibiricum, a range of aryl-substituted ketones were tested as substrates revealing a broad substrate tolerance. Kinetics as well as inhibition effects were also studied and the suitability of this method for synthetic purpose was demonstrated with acetophenone as a model substrate. Even at an elevated substrate concentration of 50 mM, excellent conversion was achieved. In addition, the impact of water-miscible co-solvents was examined, and good activities were found when using DMSO of up to 30% (v/v). Furthermore, a successful immobilization of the EsLeuDH-DM was demonstrated utilizing a hydrophobic support and a support for covalent binding, respectively, as a carrier.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 27298-97-1